Used in research to study the endocannabinoid system, particularly as a stable analog of anandamide. It selectively binds to CB1 and CB2 receptors, making it valuable for investigating pain modulation, inflammation, and neurobehavioral processes. Due to its resistance to enzymatic degradation, it has a longer duration of action in experimental models, allowing for more consistent observation of cannabinoid receptor effects. Commonly used in preclinical studies related to anxiety, addiction, and neurological disorders.